instrAction finalised a further study for development of innovative chromatography resins for endotoxin removal. The new chromatography phases base on the multi-modal instrAction technology and represent prototypes of new rugged resins with extraordinary clearance capacity for endotoxin. The resins provide new ways for endotoxin removal for proteins, API or other substances which would normally bind to anion exchange based endotoxin removal matrices. Further information is available on request.
netChrom®MLK: instrAction offers newly developed chromatographic material for the selective purification of Montelukast
Beginning of 2013 instrAction has successfully finalized some of their product developments. Based on the technology platform instrAction developed a molecule-specific phase (netChrom®MLK), for chromatographic purification of Montelukast which allows a significant more efficient and economical purification compared to the multi-stage crystallization process usually established in the downstream-processing sequence for the ingredient. Montelukast (trade name Singulair®) is an orally dosed drug for the treatment of mild to moderate asthma and allergic rhinitis. instrAction currently starts first negotiations for the out licensing of the technology to pharmaceutical drug manufacturers.
The company's quality management system was certified in November 2012 according to the standard
DIN ISO 9001:2008